Latest News and Press Releases
Want to stay updated on the latest news?
-
FYR anounced a collaboration with Mayo Clinic to advance the use of blood-based biomarkers in Parkinson’s disease (PD) research and clinical applications.
-
Delray Beach, FL, April 09, 2025 (GLOBE NEWSWIRE) -- Biomarkers Market , valued at US$54.8 billion in 2023, is forecasted to grow at a robust CAGR of 10.2%, reaching US$57.7 billion in 2024 and an...
-
Washington D.C., March 27, 2025 (GLOBE NEWSWIRE) -- International non-profit organization The Global Alzheimer’s Platform Foundation® (GAP) in collaboration with the Scottish Funding Council’s Brain...
-
Digital Neuro Biomarkers Market to Hit USD 4592.14 Million by 2032 at a CAGR of 25.96% | SNS Insider
Pune, March 06, 2025 (GLOBE NEWSWIRE) -- According to SNS Insider, The Digital Neuro Biomarkers Market in 2023 was valued at USD 538.96 million, and is expected to reach a market value of USD...
-
Pune, Feb. 24, 2025 (GLOBE NEWSWIRE) -- Biomarkers Market Size & Growth Analysis: “According to SNS Insider, the Global Biomarkers Market was valued at USD 67.92 billion in 2023 and is...
-
Pune, Feb. 18, 2025 (GLOBE NEWSWIRE) -- According to SNS Insider, The Personalized Medicine Biomarkers Market size was valued at USD 17.26 billion in 2023, is projected to reach USD 58.39 billion by...
-
Washington D.C., Feb. 18, 2025 (GLOBE NEWSWIRE) -- The Global Alzheimer’s Platform Foundation® (GAP) is pleased to welcome Roche to the Bio-Hermes-002 study. This collaboration will enhance this...
-
Washington D.C., Jan. 30, 2025 (GLOBE NEWSWIRE) -- The Global Alzheimer’s Platform Foundation® (GAP) is pleased to announce a collaboration with the Biomarkers of Aging Consortium, a consortium...
-
Washington D.C., Jan. 23, 2025 (GLOBE NEWSWIRE) -- The Global Alzheimer’s Platform Foundation® (GAP) is pleased to welcome Beckman Coulter Diagnostics as a strategic partner in the Bio-Hermes-002...
-
NEW YORK, Jan. 22, 2025 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with...